Alcon AG reported $3.17B in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
AstraZeneca USD 31.27B 286M Sep/2026
Bayer EUR 29.4B 2.87B Sep/2026
Essilor EUR 12.64B 490M Jun/2026
Fresenius EUR 8.08B 986M Sep/2026
Fresenius Medical Care EUR 7.91B 727.93M Sep/2026
GlaxoSmithKline GBP 20.72B 814M Sep/2026
GRIFOLS EUR 2.3B 59M Sep/2026
Lonza CHF 3.57B 421M Dec/2025
Merck EUR 8.96B 833M Sep/2026
Novartis USD 32.52B 777M Sep/2026
Philips EUR 7.91B 485M Sep/2026
Roche Holding CHF 28.85B 846M Jun/2026
Sanofi EUR 29.77B 2.16B Sep/2026
Smith & Nephew USD 2.05B 510M Jun/2026
Sonova Holding CHF 1.5B 303M Jun/2025
UCB EUR 4.4B 470M Dec/2025